Dermal Fillers Market Size, Trends, In-depth Analysis, Research Report Forecast up to 2028: Galderma Laboratories, L.P., and Croma Pharma are key players.

Dermal Fillers Market is expected to grow at a CAGR of 8.57% to reach a market size worth US$5.597 billion by 2028.

The prime factors propelling the market growth of dermal fillers are superior quality results and an increasing number of low-risk non-surgical, and minimally invasive procedures.

The dermal fillers market is expected to witness robust growth over the forecast period.

Dermal fillers are cosmetic injections that are given to customers who want to improve and change the current appearance of their faces, and this is opted by customers who wish to enhance their facial appearance, mass, and symmetry of facial features such as cheeks, lips, and jawline and reduce sagging of their skin.

Dermal fillers improve the skin's health by constructing collagen and elastin in the injected areas. Dermatology clinics and hospitals offer different kinds of dermal fillers that are available in the market for their consumers. In June 2021, Medytox Inc. and Dynamic Medical Technologies Company collaboration announced the development of hyaluronic-acid-based dermal fillers. In India, Kaya Clinic promises immediate results with its Juvederm dermal filler within one week after injection. Consumers can choose from several skincare products and regimens, but dermal fillers offer superior results, which have resulted in growth in the dermal fillers market demand. A dermal filler injection is a minimally invasive procedure that does not require its patients to undergo surgery or anesthesia to achieve the desired results. In 2021, The Aesthetic Society reported 1.8 million dermal filler procedures and 0.39 million other skin tightening treatments. Dermal fillers are gaining popularity due to their facial enhancement benefits and low-risk characteristics. These factors are driving the demand for the dermal fillers market.

Sample request or complete report can be purchased through the link below:

https://www.knowledge-sourcing.com/report/dermal-fillers-market

The dermal fillers market is segmented into product type, application, material, end-user, and geography.

Based on the product type, the market has been segmented into biodegradable and non-biodegradable.

Based on the application, the market has been segmented into facial line correction, facelifts, lip enhancement, and others. Based on the material, the market has been segmented into hyaluronic acid, calcium hydroxylapatite, poly-lactic acid, polymethyl-methacrylate microspheres, and others.

Based on the end-user, the market has been segmented into dermatology clinics, hospitals, and others.

By region, North America is expected to retain a considerable market share due to a rise in minimally invasive cosmetic procedures and increased aesthetics and skin clinic services. Foreign companies are expanding their operations in North America due to the growing demand for derma fillers and other cosmetic treatments. The German company Amalian announced, in December 2022, the opening of its clinic and its superior-quality dermal fillers in Canada. North American healthcare and beauty companies are investing heavily in the launch of new products, including dermal fillers. US-based pharmaceutical company AbbVie Company has developed and launched a new line of dermal fillers through its subsidiary brand Allergan Aesthetics. Considering the factors affecting the rapid growth of dermal fillers in North America, the market is expected to grow over the forecast period.

The impact of COVID-19 on the global dermal fillers market has been significant as the demand for dermal fillers decreased as people prioritized their spending on essential items and postponed elective procedures. Additionally, supply chain disruptions and production shutdowns due to the pandemic also affected the availability of dermal fillers in the market.

The major players covered in the dermal fillers market study are Sinclair, Suneva Medical, Merz Pharma, Abbvie Inc. (ALLEGRAN), Galderma Laboratories, L.P., Croma Pharma, Cytophil, Inc., Humedix, and Prollenium Medical Technologies.

This dermal fillers market has been analyzed into the following segments:

• By Product Type

o Biodegradable
o Non-biodegradable

• By Application

o Facial Line Correction
o Face Lift
o Lip Enhancement
o Others

• By Material

o Hyaluronic Acid
o Calcium Hydroxylapatite
o Poly-L-Lactic Acid
o Polymethyl-Methacrylate Microspheres
o Others

• By End-User

o Dermatology Clinics
o Hospitals
o Others

• By Geography

• North America

o USA
o Canada
o Mexico
o South America
o Brazil
o Argentina
o Others

• Europe

o UK
o Germany
o France
o Spain
o Others

• Middle East and Africa

o UAE
o Israel
o Saudi Arabia
o Others

• Asia Pacific

o Japan
o China
o India
o South Korea
o Thailand
o Vietnam
o Indonesia
o Others

Related Reports:

• Global Transdermal Drug Delivery Systems Tdds Market: https://www.knowledge-sourcing.com/report/global-transdermal-drug-delivery-systems-tdds-market

• OTC Probiotics Supplement Market: https://www.knowledge-sourcing.com/report/otc-probiotics-supplement-market

Contact Us:
Knowledge Sourcing Intelligence
Phone: +1-850-250-1698
E-Mail: info@knowledge-sourcing.com

Knowledge Sourcing Intelligence (KSI) is a market research and consulting firm publishing market research studies across ten industry verticals. KSI has a team of experienced and young professionals who focus on delivering high-quality research services to enterprises, non-government organizations, government agencies, and research institutes and organizations. We publish hundreds of reports annually centering on the niche and latest technologies. In addition, we engage with key decision-makers and stakeholders across the value chain to provide clients with a detailed analysis and bird's-eye view of the market with complete market dynamics, statistical forecasts, competitive analysis, key trends, market drivers, and challenges, and strategic recommendations for making informed decisions. Our success lies in our analysts' efforts to meet client expectations by delivering quality work within the stipulated deadlines.

This release was published on openPR.